Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

Recruiting now · Not applicable

Conditions studied: Anxiolytic Effect, Virtual Reality Immersion, Midazolam, Premedication, Dacryocystorhinostomy

In brief

The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.

Key facts

Study ID

NCT07050095

Run by

Cairo University

People needed

40

Starts

2025-06-01

Expected to finish

2025-12-30

Last updated by the study team

2025-07-03

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18-65.
• Both sexes.
• American Society of Anesthesiologists (ASA) classification: I - II.
• Patient undergoing Dacryocystorhinostomy Surgery (DCR) operation under general anesthesia.

You may not qualify if…

• Patient refusal.
• Patients with cardiac diseases.
• Patients with renal diseases.
• Patients with drug sensitivity and seizures.
• Substance abuse and addiction.
• Claustrophobia.
• Patients with cerebrovascular disease.
• Psychiatric and cognitive disorder.
• Patients with severe teary eyes and blurring of vision.
• Patients who express discomfort during the test.

Where it is running

• Cairo University — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.